Beckman Coulter said it would file for an emergency use authorization for a SARS-CoV-2 antigen test that costs only $4. Danaher Corp. (NYSE:DHR) agreed to pay about $6.8 billion in cash for ...

Our collaboration with Beckman Coulter aims to democratize access to the pTau217 antibody, developing it into a highly ...

In particular, new FDA requirements around modifying IVDs could lead labs to push for IVD vendors to validate their tests ...

Introducing the new Allegra X-14 Series. At 120 volts, it's a great alternative to the higher voltage Allegra X-15R. This benchtop centrifuge is convenient, hardworking, reliable, and will speed ...

A broad menu of high quality assays from Beckman Coulter, plus new, productivity-enhancing features on the Access 2 offer laboratories a flexible option for immunoassay testing.

BREA, Calif., July 25, 2024 /PRNewswire/ -- Beckman Coulter Diagnostics, a clinical diagnostics leader, today announced that the DxI 9000 Immunoassay Analyzer* was honored during Premier ...

Furthermore, Brennan was encouraged by the specific growth initiatives discussed for key players within the Dx segment like Cepheid and Beckman Coulter. Projections for Cepheid’s growth in the low ...

His assessment took into account Danaher’s recent Analyst Day revelations which highlighted the strengths of its Diagnostic (Dx) franchise, particularly Cepheid and Beckman Coulter. Despite the ...

Biogen, Beckman Coulter and Fujirebio have partnered to identify and develop new blood-based biomarkers for Tau pathology, a hallmark of Alzheimer’s disease. As part of the agreement ...

FULLERTON, Calif., May 14 /PRNewswire-FirstCall/ -- Beckman Coulter, Inc. (NYSE:BEC) today announced that it would not increase the price offered for shares of the ...

there have been 52 years of successful innovation using the Coulter Principle, making Beckman Coulter one of the leading companies in particle characterization today. The Multisizer™ 4 features the ...